Alzheimer's Disease: Abeta

Alzheimer's disease (AD) is a chronic neurodegenerative disease associated with accumulation of amyloid plaques, which are comprised of amyloid beta. Here is the latest research in this field.

June 2, 2020
Review

Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders

Phytotherapy Research : PTR
Muqeet WahidMuhammad Hassham Hassan Bin Asad
May 31, 2020

Development of a PET radioligand selective for cerebral amyloid angiopathy

Nuclear Medicine and Biology
Eric E AbrahamsonMilos D Ikonomovic
May 29, 2020
Review

Neuron-Glia interaction: Molecular basis of Alzheimer's Disease and Applications of Neuroproteomics

The European Journal of Neuroscience
Abdallah Mohammad IbrahimJb Senthil Kumar
May 30, 2020

Therapeutic Effects of Melatonin-Treated Bone Marrow Mesenchymal Stem Cells (BMSC) in a Rat Model of Alzheimer's Disease

Journal of Chemical Neuroanatomy
Mahdi RamezaniZoleikha Golipoor
May 28, 2020
Open Access

Neuroprotective and Anti-Inflammatory Effects of Low-Moderate Dose Ionizing Radiation in Models of Alzheimer's Disease

International Journal of Molecular Sciences
Sujin KimMinho Moon
May 30, 2020

High-Throughput Screening at the Membrane Interface Reveals Inhibitors of Amyloid-β

Biochemistry
Sarah J CoxAyyalusamy Ramamoorthy
May 30, 2020

Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases

Advances in Experimental Medicine and Biology
Vasiliki Machairaki
May 30, 2020

Alzheimer's Disease Therapeutic Approaches

Advances in Experimental Medicine and Biology
Maria Revi
June 2, 2020
Review
Open Access

Microglia and Wnt Pathways: Prospects for Inflammation in Alzheimer's Disease

Frontiers in Aging Neuroscience
Yunying Yang, Zhentao Zhang
May 30, 2020
Review

Role of Microglia in Regulating Cholesterol and Tau Pathology in Alzheimer's Disease

Cellular and Molecular Neurobiology
Shwetha NanjundaiahSubashchandrabose Chinnathambi
May 30, 2020

Amyloidogenic processing of amyloid β protein precursor (APP) is enhanced in the brains of Alcadein α-deficient mice

The Journal of Biological Chemistry
Naoya GotohTohru Yamamoto

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

4H Leukodystrophy

4H Lekodystrophy involves hypomyelination, hypogonadotropic hypogonadism and hypodontia. It is also known as POLR-3Related Leukodystrophy. 4H syndrome symptoms include delayed or abnormal puberty, issues with central nervous system signal transmission, abnormal development of teeth, and symptoms tend to progressively get worse over time. There is not yet a known cure.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-abeta/04a02fd8-ebb8-4fd7-a5af-a23ea43ba447